Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Biden urges Americans to get updated COVID-19 bivalent booster

By Brian Buntz | October 25, 2022

Joe Biden

Biden received the updated booster. [Image courtesy of the White House]

After receiving a COVID-19 bivalent booster on television, President Biden asked all eligible adults to receive their booster to help ward off a potential uptick in infections in the coming months. 

The updated vaccines from Pfizer/BioNTech (NYSE:/PFE, Nasdaq: BNTX) and Moderna (Nasdaq:MRNA) are “incredibly effective,” Biden said. “But the truth is, not enough people are getting [them].” 

“Now is the time to [get the new bivalent booster] — by Halloween, if you can,” Biden said. “That’s the best time. And that way, you can be protected for the holidays.”

COVID-19 infections and hospitalizations have risen in Europe in recent weeks. In prior surges, the Continent has often seen an uptick in COVID-19 infections before the U.S. does. 

Speaking alongside members of the White House COVID-19 Response Team, Biden said Americans could help prevent the surge in infections that have occurred over the past two winters by receiving the updated booster. 

To date, approximately 20 million Americans have received the updated COVID-19 bivalent boosters, according to CDC. That figure equates to 8.5% of those who are eligible. 

CDC Director Dr. Rochelle Walensky has echoed Biden’s advice, stating that the updated bivalent booster represent “a critical step in our fight against COVID-19.” 

“An updated vaccine can help bolster protection for our children this winter,” she said. 

A recent op-ed in the Wall Street Journal criticized the U.S. government’s decision to spend billions on updated boosters that “nobody wants.”  

The article notes that the U.S. government has seen 82.1 million vaccine doses go to waste between December 2020 and mid-May 2022. 

Several omicron subvariants are beginning to spread in the U.S., including BQ.1 and BQ.1.1.

CDC’s Advisory Committee on Immunization Practices (ACIP) estimated that if approximately half of the eligible public got an updated booster, the U.S. could prevent 25 million infections, one million hospitalizations and 100,000 deaths by March 31, 2022. 

Pfizer and Moderna are in the process of extending availability for the updated boosters to all children eligible for COVID-19 vaccination.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

institut pasteur dakar IPD African Union vaccine investment
African Union vaccine initiative receives $45M
Sen-Jam Pharma, KVK-Tech partnering for manufacturing and formulation for anti-inflammatory injectables
This image shows the Moderna logo.
Moderna resizes its manufacturing footprint for a post-pandemic era
This is the logo of Pfizer.
Pfizer to close Durham and Morrisville, North Carolina facilities amid major restructuring effort
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE